|
GLUE Monte Rosa Therapeutics Inc 1826457 |
| Balance Sheet |
|
Current Assets
|
$677,547,000.00 |
|
Assets
|
$736,428,000.00 |
|
Current Liabilities
|
$71,036,000.00 |
|
Liabilities
|
$214,512,000.00 |
|
Equity
|
$521,916,000.00 |
|
Shares Out
|
84321705.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-37,369,000.00 |
|
Investing Cash Flow
|
$-260,997,000.00 |
| Market Analysis |
Market Cap
|
$1,912,416,269.40 |
|
Price
|
$16.24 |
|
BVPS
|
6.19 |
|
PB
|
3.66 |
|
EPS
|
-1.46 |
|
PS
|
121.23 |
|
FCF
|
$-39,237,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:24 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:19 |
|
| Apr |
May |
Jun |
| 2026-03-17 |
|
|
|
2026-05-07 |
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view GLUE documents filed with the SEC.
GLUE Filings
Clear
